NCT06681051View on ClinicalTrials.gov

Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders

RecruitingOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Tendinopathy
Interventions
DEVICE

OSTENIL® TENDON

OSTENIL® TENDON is a CE-certified viscoelastic solution intended for peritendinous or intrasheath injection, containing 2 % sodium hyaluronate from fermentation.

Trial Locations (5)

10627

RECRUITING

ATOS MVZ meviva Berlin, Berlin

13589

RECRUITING

Orthopädie am Kiesteich, Berlin

14195

RECRUITING

Orthopädische Gemeinschaftspraxis ÜBAG, Berlin

14197

RECRUITING

Orthopädie Dr. Bentzin, Berlin

14482

RECRUITING

Orthopädische Praxis Dr. Fischer, Potsdam

All Listed Sponsors
lead

TRB Chemedica AG

INDUSTRY